Streetbeat News

Price Targets

FANG

Analysts have provided diverse ratings for Diamondback Energy (NASDAQ:FANG) with 15 recent evaluations. The average 12-month price target is $188.33, with a high of $225.00 and a low of $154.00. Recent actions include both raised and lowered price targets and ratings. Diamondback Energy operates in the Permian Basin with 2 billion barrels of proven reserves and a net production of 386,000 barrels per day. The company's financials show a market cap above industry average, a recent revenue decline of -3.85%, a high net margin of 39.37%, but a lower than average ROE of 5.75% and a strong ROA of 3.29%. The debt-to-equity ratio is healthy at 0.38.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 2:00 pm

ASND

Wedbush analyst Andreas Argyrides has maintained an Outperform rating on Ascendis Pharma (NASDAQ:ASND) and increased the price target from $200 to $202.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:58 pm

UAL

Raymond James analyst Savanthi Syth has maintained an Outperform rating on United Airlines Holdings (NASDAQ:UAL) but has reduced the price target from $68 to $65.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:57 pm

FOUR

Raymond James analyst John Davis has maintained an Outperform rating on Shift4 Payments (NYSE:FOUR) and increased the price target from $75 to $88.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:52 pm

MARA

Marathon Digital's stock (MARA) is trading higher following an upgrade in price target from $20 to $24 by HC Wainwright & Co, which also maintained a Buy rating on the shares.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:51 pm

RRC

Raymond James analyst John Freeman has maintained an Outperform rating on Range Resources (NYSE:RRC) but reduced the price target from $41 to $37.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:50 pm

FDX

Raymond James analyst Patrick Tyler Brown has maintained an Outperform rating on FedEx (NYSE:FDX) but reduced the price target from $279 to $275.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:48 pm

SYRE

BTIG analyst Julian Harrison has initiated coverage on Spyre Therapeutics (NASDAQ:SYRE) with a Buy rating and set a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:46 pm

FANG

Raymond James analyst John Freeman has maintained a Strong Buy rating on Diamondback Energy (NASDAQ:FANG) but has reduced the price target from $214 to $190.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:46 pm

BLND

Blend Labs' stock (BLND) is experiencing an uptick following an upgrade from Wells Fargo, which changed its rating from Equal-Weight to Overweight and increased the price target from $1.5 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:44 pm